Medtronic is upping the ante in patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic's InterStim device, an implanted ...

The partnership aims to broaden the range of support services available to individuals experiencing bladder control issues. Credit: Shidlovski / Shutterstock.com. Minze Health has reached an agreement ...

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...

Medtronic has received FDA approval for a new implant aimed at improving bladder control, with a small device placed near the ankle designed to be more convenient and accessible. Compared to other ...

Bladder control problems affect an estimated 43 million – or one in six – U.S. adults. Of those, nearly 16 million people have urge urinary incontinence, a common symptom of overactive bladder (OAB) ...

To treat a common bladder condition, Medtronic implant goes under the skin near the ankle The Minnesota medtech company’s Altaviva implant just secured FDA approval. It treats urinary urge ...

GLEN DALE, W.Va. — Reynolds Memorial Hospital has performed its first implantation of the Altaviva device, a new treatment option designed to help manage bladder control symptoms.Hospital officials ...

Okay. Hello, everyone. Thanks for joining us today. I'm Ryan Weispfenning, Vice President and Head of Investor Relations at Medtronic. Thank you for joining call showcasing the Altaviva device, which ...